Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Photochem Photobiol Sci ; 15(5): 673-81, 2016 05 11.
Article in English | MEDLINE | ID: mdl-27109559

ABSTRACT

Photodynamic inactivation (PDI) is an efficient approach for the elimination of a series of microorganisms; however, PDI involving phytopathogenic filamentous fungi is scarce in the literature. In the present study, we have demonstrated the photoinactivating properties of five cationic meso-(1-methyl-4-pyridinio)porphyrins on conidia of the phytopathogen Colletotrichum graminicola. For this purpose, photophysical properties (photostability and (1)O2 singlet production) of the porphyrins under study were first evaluated. PDI assays were then performed with a fluence of 30, 60, 90 and 120 J cm(-2) and varying the porphyrin concentration from 1 to 25 µmol L(-1). Considering the lowest concentration that enabled the best photoinactivation, with the respective lowest effective irradiation time, the meso-(1-methyl-4-pyridinio)porphyrins herein studied could be ranked as follows: triple-charged 4 (1 µmol L(-1) with a fluence of 30 J cm(-2)) > double-charged-trans2 (1 µmol L(-1) with 60 J cm(-2)) > tetra-charged 5 (15 µmol L(-1) with 90 J cm(-2)) > mono-charged 1 (25 µmol L(-1) with 120 J cm(-2)). Double-charged-cis-porphyrin 3 inactivated C. graminicola conidia in the absence of light. Evaluation of the porphyrin binding to the conidia and fluorescence microscopic analysis were also performed, which were in agreement with the PDI results. In conclusion, the cationic porphyrins herein studied were considered efficient photosensitizers to inactivate C. graminicola conidia. The amount and position of positive charges are related to the compounds' amphiphilicity and therefore to their photodynamic activity.


Subject(s)
Colletotrichum/drug effects , Colletotrichum/radiation effects , Photosensitizing Agents/pharmacology , Porphyrins/pharmacology , Cations/chemistry , Cations/pharmacology , Colletotrichum/metabolism , Light , Photosensitizing Agents/chemistry , Plants/microbiology , Porphyrins/chemistry , Singlet Oxygen/metabolism
2.
Photodiagnosis Photodyn Ther ; 12(3): 444-58, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26007240

ABSTRACT

BACKGROUND: Photodynamic therapy (PDT) is a technique that uses light and a photosensitizer, converting local molecular oxygen into singlet oxygen, which eliminates a target unhealthy tissue. It has been increasingly used for the treatment of several diseases including skin disorders. Psoriasis is a chronic inflammatory skin disease expressing immune and hyperproliferative features. OBJECTIVE: This study aimed to evaluate the effect of the photosensitizer 5,10-diphenyl-15,20-di(N-methylpyridinium-4-yl)porphyrin (Di-cis-Py+) in in vivo models whereby some psoriasis-like parameters could be investigated. METHODS: The antiinflammation and antiproliferative activities of Di-cis-Py+ photoactivated was measured by myeloperoxidase (MPO) and N-acetyl-ß-d-glucosaminidase (NAG) enzyme activity assay, measurement of IL-6, IL-1ß and TNF-α levels, evaluation of proliferating cell nuclear antigen (PCNA) levels by immunohistochemistry and by Western blot. RESULTS: Treatment involving PDT and Di-cis-Py+ resulted in reduction of edema, cellular infiltration, proinflammatory cytokines, as well as reduced hyperproliferation of the epidermis. All the evaluated parameters were promoted by topical application of phlogistic agents and are similar to that observed in lesions of psoriatic skin. CONCLUSION: The results shows the advantage of topical application, do not cause apparently photosensitivity and have effects comparable to dexamethasone, a first-line drug for the treatment of the disease.


Subject(s)
Inflammation Mediators/metabolism , Photochemotherapy/methods , Photosensitizing Agents/pharmacology , Porphyrins/pharmacology , Acetylglucosaminidase/metabolism , Animals , Cytokines/metabolism , Female , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Keratinocytes/drug effects , Mice , Peroxidase/metabolism , Photochemotherapy/adverse effects , Proliferating Cell Nuclear Antigen/metabolism , Psoriasis/drug therapy , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...